Association between metabolic syndrome and venous thromboembolism after total joint arthroplasty: a meta-analysis of cohort studies

[1] Trivedi NN(2019)Venous thromboembolism chemoprophylaxis in total hip and knee arthroplasty: a critical analysis review JBJS Rev. 7 e2-2779

[2] Fitzgerald SJ(2020)Venous thromboembolism rates after hip and knee arthroplasty and hip fractures BMC Musculoskelet Disord. 21 95-798

[3] Schmaier AH(2019)Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016 J Arthroplasty. 34 2774-303

[4] Wera GD(2017)Venous thromboembolism prophylaxis in total hip arthroplasty and total knee arthroplasty patients: from guidelines to practice J Am Acad Orthop Surg. 25 789-347

[5] Mula V(2012)Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review JAMA. 307 294-479

[6] Parikh S(2018)What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients? Arthroplast Today. 4 343-17

[7] Suresh S(2019)Metabolic syndrome in children and adolescents: diagnostic criteria, therapeutic options and perspectives Curr Obes Rep. 8 472-42

[8] Bottle A(2017)The definition and prevalence of obesity and metabolic syndrome Adv Exp Med Biol. 960 1-48

[9] Loeffler M(2012)Platelet activation in obesity and metabolic syndrome Obes Rev. 13 27-680

[10] Alam M(2012)Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease Biomed Mater Eng. 22 35-1501

[1] Trivedi NN(2019)Venous thromboembolism chemoprophylaxis in total hip and knee arthroplasty: a critical analysis review JBJS Rev. 7 e2-2779

[2] Fitzgerald SJ(2020)Venous thromboembolism rates after hip and knee arthroplasty and hip fractures BMC Musculoskelet Disord. 21 95-798

[3] Schmaier AH(2019)Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016 J Arthroplasty. 34 2774-303

[4] Wera GD(2017)Venous thromboembolism prophylaxis in total hip arthroplasty and total knee arthroplasty patients: from guidelines to practice J Am Acad Orthop Surg. 25 789-347

[5] Mula V(2012)Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review JAMA. 307 294-479

[6] Parikh S(2018)What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients? Arthroplast Today. 4 343-17

[7] Suresh S(2019)Metabolic syndrome in children and adolescents: diagnostic criteria, therapeutic options and perspectives Curr Obes Rep. 8 472-42

[8] Bottle A(2017)The definition and prevalence of obesity and metabolic syndrome Adv Exp Med Biol. 960 1-48

[9] Loeffler M(2012)Platelet activation in obesity and metabolic syndrome Obes Rev. 13 27-680

[10] Alam M(2012)Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease Biomed Mater Eng. 22 35-1501